[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
June 1, 2011

Error in: Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention

JAMA. 2011;305(21):2174. doi:10.1001/jama.2011.711

Errors: In the Original Contribution entitled “Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention,” published in the March 16, 2011, issue of JAMA (2011;305[11]:1097-1105), data in a figure were misplaced, a conflict of interest statement was omitted, and Dr Stillabower's name was misspelled.

The hazard ratios in Figure 2 were placed in the wrong panels. Dr Topol's conflict of interest statement should have read: “Dr Topol reported receiving consulting fees from Bristol-Myers Squibb/sanofi-aventis and Daiichi Sankyo/Lilly & Co.”

×